Abstract PS5-12-16: A Phase 2 Trial of (Z)-endoxifen + Goserelin as Neoadjuvant Treatment for Premenopausal Women with ER+, HER2-, Breast Cancer (EVANGELINE)
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: M. P. Goetz, V. J. Suman, C. Lopez, H. Erickson, L. Beaulieu, S. S. Hammer, L. Mina, R. Leon-Ferre, K. N. Hunt, M. Piltin, A. Degnim, J. N. Ingle, J. C. Boughey, B. A. Sarah, J. M. Reid, M. Schellenberg, J. R. Hawse, P. Advani, K. Giridhar, F. Batalini, D. Flora, J. M. Jones, N. A. Bagegni, J. Jakub, V. Abramson, V. Dabak, W. J. Irvin, E. Sima, K. Seema, S. C. Quay
Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Atossa Therapeutics (United States), Mayo Clinic in Arizona, Mayo Clinic in Florida, Mayo Clinic Hospital, St. Elizabeth Healthcare, Avera Health, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Henry Ford Hospital, University of Arizona, Northwestern University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129342645
Cites:
Cited by:
Related to: